Non-viral siRNA delivery systems for pancreatic cancer therapy

Abstract

The serious drawbacks of conventional pancreatic ductal adenocarcinoma (PDAC) therapy like nonspecific toxicity and high resistance to chemo and radiation therapy, prompted the development and application of countless siRNA-based therapeutics. Significant technological success has been achieved in this area; however, the major challenges to siRNA-based therapeutics becoming a new paradigm in the pancreatic cancer therapy stem from enzymatic digestion, off-target effects, difficulty to enter cells, induction of innate immune responses, and renal clearance. Recent advances in drug delivery systems hold great promise for improving siRNA-based therapeutics and developing a new class of drugs, nano-siRNA drugs. However, a number of fundamental questions, regarding toxicity, immunostimulation, and poor knowledge of nano-bio interactions, need to be addressed before clinical translation. In this review, we provide recent achievements in designing and development of various non-viral delivery vehicles for pancreatic cancer therapy. More importantly, co-delivery of conventional anticancer drugs with siRNA as a new revolutionary pancreatic cancer combinational therapy is completely discussed.

Effectiveness of photodynamic therapy on the treatment of chronic periodontitis: a systematic review during 2008–2023

“…PDT is a chemical process that produces exogenous ROS in the presence of oxygen when PS is placed in the target area. ROS are the main factor in the effectiveness of the PDT mode of action by destroying abnormal cancer cells (Zheng et al, 2023) and pathogenic bacteria (Ghorbani et al, 2018) that are specifically targeted to be destroyed. On the other hand, under normal conditions, 90% of the ROS in the body are produced by the mitochondrial electron chain in response to hypoxia, ischemia, aging, etc.…”

Strategies for combating antibiotic resistance in bacterial biofilms

“…Upon return to ground state, these electrons can react with organic compounds inside cells, leading to free radical generation. These free radicals cause oxidative damage to the cell, promoting apoptosis (Ghorbani et al, 2018). It is unlikely that development of resistance to APDT would occur due to the non-specific nature of the target.…”

Antimicrobial Photodynamic Therapy for the Remote Eradication of Bacteria

“…[29] To overcome these flaws, subsequent modifications were made to the structure of phthalocyanine, such as the addition of Zn(II) which is one of the most commonly studied phthalocyanine-based photosensitizer for APDT. [41] For instance, Li and his co-workers reported a new nanodot based on a single phthalocyanine molecule (PcA) that could self-assemble in aqueous solution and remain stable for a week in the absence of light. The self-assembly of PcA forms NanoPcA that can effectively produce ROS upon the irradiation of light via the type I mechanism.…”